drugset / Trial / NCT00265655
Satraplatin for Patients With Metastatic Breast Cancer (MBC)
NaSingle-groupOpen-labelTreatment
Summary
To determine the objective response rate (ORR) of oral satraplatin in patients with Metastatic Breast Cancer.
Timeline
- Start
- 2005-11
- Primary completion
- 2008-01
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Satraplatin | Other / unclassified | 80 mg/m2 | Oral |